eGnome analyzes the gut and vaginal microbiomes using cutting-edge RNA technology and third-generation Sequencing. Based on this technology, we focus on developing customized probiotic strains and microbiome-based therapeutics. Our team analyzes customers’ Microbiome data to recommend optimal nutrients and biotics, helping them lead healthier and more balanced lives.

eGnome's research and expertise have been internationally recognized, with numerous papers published in renowned scientific journals such as Nature and Science. Additionally, we continuously enhance our expertise through participation in various international consortia and collaborative research with leading researchers both domestically and internationally.

Our personalized solutions are based on customers' microbiome data. We provide tailored nutrients and probiotics optimized for each individual, improving not only gut health but also overall well-being. Our approach respects the unique individuality of each customer and offers scientifically proven, personalized health management solutions.

We predict various diseases involving the microbiome through species-level microbiome analysis. By assessing disease risk, we propose microbiome analysis as a tool for not only disease prevention but also new health management methods.

eGnome's goal is to help everyone lead a healthy life. Our personalized healthcare products are developed based on the latest scientific research and technology, and we strive to achieve our customers' health goals. We look forward to your continued support and interest.